# Eli Dorf (Bask Health) - What is Hims’ moat if anyone can launch a telehealth startup overnight?

Page: https://stenobird.com/podcast/hims-house-7026583/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight
Text version: https://stenobird.com/podcast/hims-house-7026583/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight.md
Podcast: [Hims House](https://stenobird.com/podcast/hims-house-7026583)
Published: 2026-05-19T12:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Eli-Dorf-Bask-Health---What-is-Hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight-e3jia0r
Audio file: https://anchor.fm/s/10e9c0874/podcast/play/120186331/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-18%2F424420815-44100-2-2246ed7cb51ca.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight
Duration seconds: 3353

## Resource

In episode 67 of Hims House, Jonathan Stern hosts Eli Dorf, founder and president of Bask Health. Bask provides the operating infrastructure for telehealth brands to launch quickly, choose pharmacy and clinical partners, route patients, process payments, and fulfill medications. Eli explains why outsourced infrastructure can let small teams scale fast, what Medvi’s rise reveals about the telehealth stack, and why he sees Hims’ strongest moat as brand trust and customer scale rather than pure technology. They also discuss pricing pressure in compounded GLP-1s, FDA enforcement, 503A compounding latitude, and why fragmentation could keep compressing margins. The conversation closes with peptides, LegitScript and payments hurdles, trusted brands, wearables, the health super app race, and whether Ro could go public. 00:00 - Sponsor: Superpower 02:18 - What Bask Health does 03:19 - Launching a telehealth brand overnight 07:21 - Can anyone copy Hims? 14:28 - Bask's business model 16:28 - Fragmentation hits telehealth margins 19:48 - Medvi’s cautionary tale 21:56 - What are Hims’ real moats 25:29 - Data, AI, and wearables 26:39 - Should Hims sell hardware? 30:15 - FDA pressure on GLP-1s 33:44 - Peptides as the next GLP-1 moment 36:48 - Payment processing and LegitScript 41:05 - Why peptide trust matters 43:52 - The health super-app race 47:44 - Ro vs Hims 50:45 - Will Ro go public? Disclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/hims-house-7026583/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.